PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-gamma coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-alpha, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-alpha. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is elevated in liver in mouse models of diabetes and regulates the expression of TRB3, an inhibitor of insulin-dependent AKT activation [87, 88].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [88]
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“jpg" NDATA ITEM> ]> Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscl”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“Despite its importance in promoting mitochondrial function in skeletal muscl”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649 · cited 1×
“The hypoglycemic fatty liver phenotype in PGC-1 knockdown mice is reminiscent of the phenotype of PPAR-α-deficient mice, which have hepatic steatosis and hypoglycemi”
BackgroundCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400 · cited 1×
“Overexpression of PPAR-α and its heterodimeric partner RX”
BackgroundSelf-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“Free fatty acids are thought to inhibit glucose us”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“Both TRB-3 mRNA and PGC-1 mRNA were elevated in LIRKO mice, which have a knockout of the insulin receptor in live”
BackgroundSelf-citationTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · cited 1×
“In the fed state, insulin inhibits hepatic glucose output through a cascade of phospholipid-dependent kinases that activate Akt/PKB by phosphorylating it at Thr308 and Ser473 (refs”
Background
Cited by
Items 401–500 of 552
Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1α
Li, S., Arning, E., Liu, C., Vitvitsky, V., Hernandez, C., Banerjee, R. V., Bottiglieri, T., & Lin, J. D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90719.2008 · Cited by 18
Minocha, S., Villeneuve, D., Praz, V., Moret, C., Lopes, M., Pinatel, D., Rib, L., Guex, N., & Herr, W. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00405-18 · Cited by 15
Wang, L., Guo, Y., Pan, M., Li, X., Huang, D., Liu, Y., Wu, C., Zhang, W., & Mai, K. (2021) · Genes · doi:10.3390/genes12020297 · Cited by 16
“In PGC-1-deficient mice, mRNAs encoding PEPCK and G6Pase reduced, along with fasting glucose levels [77].”
BackgroundT3-mediated gene expression is independent of PGC-1α
Wulf, A., Harneit, A., & Weitzel, J. M. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.02.008 · Cited by 15
Transcriptional co-factors and hepatic energy metabolism
Sommerfeld, A., Krones, A., & Herzig, S. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.020 · Cited by 15
Self-citationHuang, W., Yu, J., Jia, X., Xiong, L., Li, N., & Wen, X. (2012) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x12500541 · Cited by 14
Corral‐Jara, K. F., Cantini, L., Poupin, N., Ye, T., Rigaudière, J., Vincent, S. D. S., Pinel, A., Morio, B., & Capel, F. (2020) · Nutrients · doi:10.3390/nu12123864 · Cited by 16
Qin, J., Ni, F., Lou, J., Zhang, W., Xu, S., Liu, H., Fang, Q., Wang, Z., Liu, J., Men, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096089 · Cited by 14
RetractedTribbles 3 regulates protein turnover in mouse skeletal muscle
Choi, R. H., McConahay, A., Jeong, H., McClellan, J. L., Hardee, J. P., Carson, J. A., Hirshman, M. F., Goodyear, L. J., & Koh, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.134 · Cited by 14
Cui, A.-D., Gai, N.-N., Zhang, X., Jia, K.-Z., Yang, Y., & Song, Z. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-52 · Cited by 13
“TRIB3 (a mammalian tribbles homolog, also known as TRIB3/NIPK, gene ID 57761), has been reported by most studies [5,6], although not all studies [7], implicated in the regulation of insulin signal transduction by binding to and inhibiting Akt phosphorylation and to play a role in insulin resistance [5,6].”
BackgroundInhibition of Hepatic Glycogen Synthesis by Hyperhomocysteinemia Mediated by TRB3
Liu, W., Ma, L., Liu, W.-H., Zhou, W., Zhang, K., & Zou, C. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.052 · Cited by 18
Lou, P., Lucchinetti, E., Wawrzyniak, P., Morsy, Y., Wawrzyniak, M., Scharl, M. M., Krämer, S. D., Rogler, G., Hersberger, M., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000412 · Cited by 13
Wang, Y., Zhao, H., Yang, L., Zhang, H., Yu, X., Fei, W., Zhen, Y., Gao, Z., Chen, S., & Ren, L. (2022) · Bioengineered · doi:10.1080/21655979.2022.2045837 · Cited by 12
Liu, X., Kong, J., Song, W., & Lü, Y. (2009) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(10)60003-x · Cited by 12
Association of TRB3 gene Q84R polymorphism with type 2 diabetes mellitus in Chinese population
Shi, Z., Liu, J., Guo, Q., Ma, X., Linna, S., Xu, S., Gao, H., Yuan, X., & Zhang, J. (2009) · Endocrine · doi:10.1007/s12020-009-9162-6 · Cited by 12
“family of proteins, disrupts insulin signaling by binding directly to Akt and blocking activation of the kinase [5, 6] and may be involved in metabolic syndrome by inhibiting activation of PKB [7].”
BackgroundRegulation of exercise-stimulated glucose uptake in skeletal muscle
Koh, H.-J. (2016) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2016.21.2.61 · Cited by 15
Chen, P., Zhao, H., Wu, M., He, S., Yuan, T., Yi, X., Liu, S., Pan, Y., Li, Q., Wang, S., et al. (2020) · Animal Biotechnology · doi:10.1080/10495398.2020.1796697 · Cited by 12
Prudente, S., Morini, E., & Trischitta, V. (2009) · Acta Diabetologica · doi:10.1007/s00592-008-0087-y · Cited by 13
Nakamichi, S., Senga, Y., Inoue, H., Emi, A., Matsuki, Y., Watanabe, E., Hiramatsu, R., Ogawa, W., & Kasuga, M. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0145 · Cited by 13
Balampanis, K., Chasapi, A., Kourea, E. P., Tanoglidi, A., Hatziagelaki, E. E., Lambadiari, V., Dimitriadis, G., Lambrou, G. Ι., Kalfarentzos, F., Melachrinou, M., et al. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.08.002 · Cited by 13
Mohamed, M. A., Ahmed, M. A., Elbast, S. A. A., & Ali, N. A. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00394-2 · Cited by 13
Protection from renal fibrosis, putative role of TRIB3 gene silencing
Ding, W., Li, W., Ti, Y., Bi, X., Sun, H. Z., Wang, Z., Zhang, Y., Zhang, W., & Zhong, M. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.12.003 · Cited by 12
The roles ofPPARsin human diseases
Li, J., & Liu, Y. (2018) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2018.1475673 · Cited by 13
The Molecular Basis of PPAR Function
Barak, Y., & Lee, C. (2010) · PPAR Research · doi:10.1155/2010/510530 · Cited by 15
“Amino Acid metabolism ABAT [24, 159], Acmsd [159], AGXT2 [24, 160], Arg1 [160], ASL [24, 160], Ass1 [160], CBS [24, 159], CPS-1 [24, 160], Cth [159], Got1 [160], Got2 [62, 64, 160, 161], Gls [160], GLS2 [159], GPT [24, 159], Hal [159], Hpd [159], OAT [24, 159], ODC1 [24, 62, 159], OTC [24, 62, 160], PAH [24, 159], PSA…”
BackgroundSelf-citationBerberis integerrima ameliorates insulin resistance in high- fructose-fed insulin-resistant rats.
Fallah, H., Akbari, H., Abolhassani, M., Mohammadi, A., & Gholamhoseinian, A. (2017) · PubMed Central · doi:10.22038/ijbms.2017.9409 · Cited by 13
Proteomic analysis of livers from a transgenic mouse line with activated polyamine catabolism
Cerrada‐Gimenez, M., Häyrinen, J., Juutinen, S., Reponen, T., Jänne, J., & Alhonen, L. I. (2009) · Amino Acids · doi:10.1007/s00726-009-0420-y · Cited by 10
“Activation of hepatic PGC-1a is considered as a sign of diabetes due to its control over the gluconeogenesis that might increase hepatic glucose output ( Koo et al. 2004 ).”
BackgroundInfluentialFan, Y., Na, S., Jung, Y. S., Radhakrishnan, K., & Choi, H. (2023) · Steroids · doi:10.1016/j.steroids.2023.109226 · Cited by 9
Dore, L., Durand, E., Bonafos, B., Chaiyut, J., Vaysse, L., Liengprayoon, S., Gaillet, S., Pessemesse, L., Lambert, K., Bertrand‐Gaday, C., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114945 · Cited by 10
Insights into energy balance dysregulation from a mouse model of methylmalonic aciduria
Lucienne, M., Gerlini, R., Rathkolb, B., Calzada‐Wack, J., Forny, P., Wueest, S., Kaech, A., Traversi, F., Forny, M., Bürer, C., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad100 · Cited by 9
Somvanshi, P. R., Patel, A. K., Bhartiya, S., & Venkatesh, K. V. (2016) · RSC Advances · doi:10.1039/c5ra18128c · Cited by 9
Exploring the Multi-Tissue Crosstalk Relevant to Insulin Resistance Through Network-Based Analysis
Yang, L., Yang, L., Wang, X., Xing, H., Zhao, H., Xing, Y., Zhou, F., Wang, C., Song, G., & Ma, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.756785 · Cited by 10
Na, R., Ma, C., Liu, Q., Wu, L., Zheng, X., & Liu, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5602 · Cited by 10
Relationship between Muscle Mass/Strength and Hepatic Fat Content in Post-Menopausal Women
Zhang, Y., Lu, D., Wang, R., Fu, W., & Zhang, S. (2019) · Medicina · doi:10.3390/medicina55100629 · Cited by 11
Kanwar, Y. S. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00479.2010 · Cited by 9
Tribbles homologue 3 (TRIB3) and the insulin-resistance genes in type 2 diabetes
Bèguinot, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1824-7 · Cited by 9
Mutlu, B., Sharabi, K., Sohn, J. H., Yuan, B., Latorre‐Muro, P., Qin, X., Yook, J.-S., Lin, H., Yu, D., Camporez, J. P., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.09.001 · Cited by 9
Upregulation of Tribbles decreases body weight and increases sleep duration
Popovic, R., Yu, Y., Leal, N. S., Fedele, G., Loh, S. H. Y., & Martins, L. M. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049942 · Cited by 9
“Human TRIB3 has been shown to regulate insulin signalling by acting as an inhibitor of Akt (Du et al., 2003; Koo et al., 2004), and the presence of a single-nucleotide polymorphism (SNP) in TRIB3 is reported to be a risk factor for T2DM (Prudente et al., 2009).”
ADrosophilamodel of insulin resistance associated with the human Trib3 Q/R polymorphism
Fischer, Z., Das, R., Shipman, A., Fan, J.-Y., Pence, L., Bouyain, S., & Dobens, L. L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030619 · Cited by 9
“Overexpression of Trib3 decreases Akt protein activation in the liver and muscle, whereas knockdown of Trib3 expression increases Akt in these tissues (Hegedus et al., 2007; Koo et al., 2004; Matos et al., 2010; Matsushima et al., 2006; Wang et al., 2009).”
Rondinone, C. M. (2006) · Endocrinology · doi:10.1210/en.2006-0147 · Cited by 9
“To obtain efficient and long-lived gene silencing using RNAi in cells and tissues, many groups have developed a variety of viral vectors to deliver siRNAs both in vitro and in vivo (47, 48), but continued work is needed to achieve the efficiency required.”
Guan, H., Holland, K., Qwarnström, E. E., Dower, S., & Kiss‐Toth, E. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2007.02.011 · Cited by 8
Technology Insight: small, noncoding RNA molecules as tools to study and treat endocrine diseases
Kolfschoten, I., & Regazzi, R. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0674 · Cited by 8
“Another study showed that adenoviral delivery of an siRNA against peroxisome proliferator-activated receptor γ coactivator 1β (Ppargc-1β; also known as Pgc-1β) into mouse liver resulted in fasting hypoglycemia”
BackgroundCaloric Restriction and Sirtuins as New Players to Reshape Male Fertility
André, D. C. A., Oliveira, P. F., Alves, M. G., & Martins, A. D. (2025) · Metabolites · doi:10.3390/metabo15050303 · Cited by 7
“Experiments involving SIRT1 activators and transgenic SIRT1 mice emphasize the correlation between SIRT1 and lower insulin and fasted glucose levels, underscoring its pivotal role in fostering insulin sensitivity [81,82].”
Li, J., Huang, Y., Yang, X., Cai, Y., Wang, Y., Dai, W., Jiang, L., Wang, C., & Wen, Z. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101927 · Cited by 7
“Knockdown of hepatic TRB3 expression in mice improved glucose tolerance and insulin sensitivity, whereas over-expression of TRB3 resulted in glucose intolerance and insulin resistance [14,24].”
BackgroundKarimzadeh, K., Unniappan, S., & Zahmatkesh, A. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-05089-w · Cited by 8
“Additionally, it facilitates the expression of enzymes responsible for fatty acid production, including FAS (Horton et al., 2002; Koo et al., 2004).”
Dietary Iron, Circadian Clock, and Hepatic Gluconeogenesis
Kalhan, S. C., & Ghosh, A. (2015) · Diabetes · doi:10.2337/db14-1697 · Cited by 7
The highly efficient powerhouse in the Wistar audiogenic rat, an epileptic rat strain
Dechandt, C. R. P., Vicentini, T. M., Lanfredi, G. P., da Silva-Júnior, R. M. P., Espreáfico, E. M., de Oliveira, J. A. C., Faça, V. M., Garcia‐Cairasco, N., & Alberici, L. C. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00254.2018 · Cited by 7
“In in vivo models of overexpression of PGC1 , it has been observed that gluconeogenesis is active (20, 60).”
BackgroundEnhanced Macrophage Tribbles-1 Expression in Murine Experimental Atherosclerosis
Sung, H. Y., Francis, S., Arnold, N. D., Holland, K., Ernst, V., Angyal, A., & Kiss‐Toth, E. (2012) · Biology · doi:10.3390/biology1010043 · Cited by 9
“A controlling role for tribbles has been implicated in cell division [8,9] as well as in hormone induced cellular responses, including insulin [10] and pro-inflammatory cytokines [6].”
BackgroundConditional Animal Models for the Study of Lipid Metabolism and Lipid Disorders
Bock, H. H., Herz, J., & May, P. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_17 · Cited by 6
Resveratrol Promotes Gluconeogenesis by Inhibiting SESN2-mTORC2-AKT Pathway in Calf Hepatocytes
Wang, G., Qin, S., Geng, H., Zheng, Y., Li, R., Xia, C., Chen, L., Yao, J., & Deng, L. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.05.005 · Cited by 6
Heo, H., Kim, E., Jeon, S.-M., Kwon, E., Shin, S., Paik, H., Hur, C., & Choi, M. (2013) · Molecules and Cells · doi:10.1007/s10059-013-2336-3 · Cited by 6
“In accordance with this, forced overexpression of Ppargc1a in primary hepatocytes drove gluconeogenic gene expression (Yoon et al., 2001) whereas a knockdown of Ppargc1a by short interfering RNA in the mouse liver significantly reduced Pepck and G-6Pase (Koo et al., 2004).”
BackgroundJang, Y. Y., Kim, N. K., Kim, M.-K., Lee, H., Kim, S. J., Kim, H. S., Seo, H.-Y., Lee, I. K., & Park, K. G. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.5.312 · Cited by 6
“TRB3 is expressed during fasting in the liver through the activation of the PPAR-α/PGC-1α pathway and causes insulin resistance by suppressing Akt/PKB activity [13,27].”
BackgroundEwing, G. W. (2012) · The Open Systems Biology Journal · doi:10.2174/1876392801205010001 · Cited by 11
Trb3 is Elevated in Psoriasis Vulgaris Lesions and Mediates Hacat Cells Proliferation in Vitro
Yu, X., Song, T., Zhang, L.-W., Su, Y., Wang, K.-Y., & Sun, Q. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000453 · Cited by 6
Liu, Y., Yang, C. C., Feng, X., Qi, L., Guo, J., Zhu, D., Thai, P. N., Zhang, Y., Zhang, P., Sun, M., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000196 · Cited by 7
Tan, L., Chen, Z., Ruan, Y., & Xu, H. (2022) · Epigenetics · doi:10.1080/15592294.2022.2086675 · Cited by 6
RNAi in medicine: current and future perspectives
Reddy, L. S., Sarojamma, V., & Ramakrishna, V. (2006) · Biotechnology and Molecular Biology Reviews · doi:10.5897/bmbr.9000009 · Cited by 6
Recent Advances in Hepatic Metabolic Regulation by the Nuclear Factor Rev-erbɑ
Zhang, Q., Chen, Y., Li, J., Xia, H., Tong, Y., & Liu, Y. (2024) · Current Drug Metabolism · doi:10.2174/0113892002290055240212074758 · Cited by 6
Tissue-specific implications of mitochondrial alterations in aging
Liu, D., Li, H., Lü, J., & Bai, Y. (2013) · Frontiers in Bioscience-Elite · doi:10.2741/e654 · Cited by 7
Cao, Y., Song, J., Shen, S., Fu, H., Li, X., Xu, Y., Wang, A., Li, X., & Zhang, M. (2017) · Oncotarget · doi:10.18632/oncotarget.20752 · Cited by 5
Obesity-induced TRB3 negatively regulates Brown adipose tissue function in mice
Jeong, H., Choi, R. H., & Koh, H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.01.103 · Cited by 7
Bogdanová, K., Uherková, L., Poczatková, H., Rypka, M., & Veselý, J. (2007) · Biomedical Papers · doi:10.5507/bp.2007.040 · Cited by 5
Saleh, N., Elayan, H. E., & Zihlif, M. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.184 · Cited by 5
“Koo and coworkers demonstrated that PGC-1α deficient mice experience fasting hypoglycemia and enhanced liver insulin sensitivity (13).”
BackgroundDouble Tribble: Two TRIB3 Variants, Insulin, Akt, and eNOS
Fleming, I. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169250 · Cited by 5
Yang, Y., Yu, S., Rong, H., Lei, Z., Yang, C., Wu, H., Zhang, T., Yang, F., Nie, Y., Chen, L., et al. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12650 · Cited by 4
Muscle PGC‐1α Overexpression Drives Metabolite Secretion Boosting Subcutaneous Adipocyte Browning
Miro, C., Menale, C., Acampora, L., Nappi, A., Sagliocchi, S., Restolfer, F., Torabinejad, S., Stornaiuolo, M., Dentice, M., & Cicatiello, A. G. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31480 · Cited by 5
“In addition, PGC ‐ 1 α activation is essential for brown fat thermo-genesis (Puigserver et al. 1998), hepatic gluconeogenesis (Koo et al. 2004), cardiac homeostasis (Arany et al. 2005), and brain axonal integrity (Lin et al. 2004).”
Regulation of hepatic insulin sensitivity by activating signal co-integrator-2
Kim, G. H., Lee, K. J., Oh, G., Yoon, J. H., Kim, H. W., & Kim, S. (2012) · Biochemical Journal · doi:10.1042/bj20120861 · Cited by 4
Higuchi, S., Fujikawa, R., Nakatsuji, M., Yasui, M., Ikedo, T., Nagata, M., Mishima, K., Irie, K., Matsumoto, M., Yokode, M., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00035.2018 · Cited by 4
Physiological Functions of FBW7 in Metabolism
Zhang, J., Kong, D., Huang, X., Yu, R., & Yang, Y. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1816-8903 · Cited by 4
Caüzac, M., Kohl, C., Girard, J. R., & Pégorier, J. P. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.020 · Cited by 4
Correlation between PPAR Gene Polymorphisms and Primary Nephrotic Syndrome in Children
Jin, J., Ding, G., Bao, H., Chen, Y., Han, Y., Zhao, F., Huang, S., & Zhang, A. (2013) · PPAR Research · doi:10.1155/2013/927915 · Cited by 4
Wu, X., & Garvey, W. T. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch7 · Cited by 6
Martin, M., Reidhaar-Olson, J. F., & Rondinone, C. M. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.5.455 · Cited by 4
Wang, X., Li, M., Chi, Z., Wang, M., Liu, J., Li, A., Song, B., & Tong, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1769545 · Cited by 4
“Conversely, in a rat model of T2DM, the use of gene silencing technology to knock down TRB3 effectively improves insulin resistance and myocardial injury (26, 27).”
Golinska, M. A., Stubbs, M., Harris, A. L., Boros, L. G., Madhu, B., McIntyre, D. J. O., & Griffiths, J. R. (2022) · Cells · doi:10.3390/cells11223595 · Cited by 5
고진호, Kim, K., & Kim, H. (2015) · Exercise Science · doi:10.15857/ksep.2015.24.4.407 · Cited by 4
Hong, M. S., Kim, H. K., Shin, D. H., Song, D. K., Ban, J. Y., Kim, B. S., & Chung, J. (2008) · KUMeL Repository (Keimyung University) · Cited by 4
Molecular mechanisms of cachexia in chronic disease
Kyrana, E., Briggs, S., & Dhawan, A. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.87 · Cited by 4
PPARα, A Key Regulator of Hepatic Energy Homeostasis in Health and Disease
Leuenberger, N., & Wahli, W. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_20 · Cited by 4
Hepatic Fatty Acid Metabolism and Dysfunction
Silver, D. L. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch18 · Cited by 3
Dutta, D., Behera, A., Roy, D., Sukla, S., & Banerjee, S. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.111954 · Cited by 2
Yang, D., Song, X., Zeng, X., Cao, Z., Xiang, W., Xian, X., Yuan, L., Zhang, Z., & Zheng, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08298-1 · Cited by 3
Wang, J., Chen, X., Chen, D., Yang, S., Wang, J., Chen, M., & Zhu, G. (2026) · MedComm · doi:10.1002/mco2.70671 · Cited by 3
Control of Gene Expression by RNAi: A Revolution in Functional Genomics
Kumar, S., & Salar, R. K. (2017) · Springer eBooks · doi:10.1007/978-981-10-4732-9_2 · Cited by 2
Kiss‐Toth, E. (2005) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003644.01 · Cited by 2
The Liver in Metabolic Syndrome
D’Amore, S., Palasciano, G., & Moschetta, A. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_3 · Cited by 3
Thermogenesis and the Metabolic Syndrome
Bonet, M. L., Picó, C., & Palou, A. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50017-6 · Cited by 2
Rice Bran Oil Ameliorates Hepatic Insulin Resistance in Fructose Fed-Rats
Ahmed, M. A., Ali, N. A., Elbast, S. A. A., & Mohamed, M. A. (2018) · The Egyptian Journal of Hospital Medicine · Cited by 2
Sato, T., Goto‐Inoue, N., Kimishima, M., Jike, T., Minei, R., Ogura, A., Nagoya, H., & Mori, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-10521-4 · Cited by 2
Role of PPARs in the Pathogenesis of the Metabolic Syndrome
Medina‐Gómez, G., Gray, S. L., & Vidal‐Puig, A. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50015-2 · Cited by 3
Lattimer, J. M. (2012) · K-State Research Exchange (Kansas State University) · Cited by 2
Hepatic Gene Expression Profiling to Predict Future Lactation Performance in Dairy Cattle
Doelman, J. (2011) · The Atrium (University of Guelph) · Cited by 2
Millet, Y. A., Meisner, J. S., Tan, J., Jose, A., Humphries, E., Miller, K. J., Bayne, C. F., McComb, M., Giuggio, M., Konopnicki, C. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.04.487010 · Cited by 2
Genomic Insights Into Carnivorous Fish in the Characiformes
Zhao, S., Mei, X., Zhang, Z., Xia, T., Zhou, S., Dong, Y., He, S., Yao, Z., Li, Y., Yang, X., et al. (2026) · Ecology and Evolution · doi:10.1002/ece3.73478 · Cited by 1
Muscle-Specific PPAR β/δ Agonism May Provide Synergistic Benefits with Life Style Modifications
Erol, A. (2007) · PPAR Research · doi:10.1155/2007/30578 · Cited by 3
“However, PGC1α has been shown to inhibit the insulin signaling pathway in the liver, and increased hepatic PGC1α expression could be expected to stimulate hepatic glucose output contributing to the hyperglycemic state [18].”
BackgroundKim, S. Y., Kim, J.-H., Bae, H. Y., & Lee, B.-R. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.3.161 · Cited by 1
Sakai, Y., Fukamachi, K., Futakuchi, M., Miyoshi, I., Tsuda, H., Suzui, M., & Hayashi, H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00260 · Cited by 1
Environment-Gene interaction in common complex diseases: New approaches
Toscano, W. A., Sehgal, H., Yang, E. A., Spaude, L., & Bettmann, F. A. (2014) · AIMS molecular science · doi:10.3934/molsci.2014.4.126 · Cited by 1
Miele, L., Cefalo, C., Forgione, A., Gasbarrini, G., & Grieco, A. (2010) · Recenti Progressi in Medicina · doi:10.1701/515.6148 · Cited by 1
Impact of Metabolic Syndrome on Fibrosis Progression in Chronic Viral Hepatitis B Infection
Aygün, C. (2015) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000175 · Cited by 1
Jeong, H., Bagalkot, T. R., Kim, H. S., Han, Y., Kim, M., Lim, S. T., & Sohn, M. (2020) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-020-00634-x · Cited by 1
Metadata
- Authors
- Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Montminy, Marc
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-04-25
- Volume
- 10
- Issue
- 5
- Pages
- 530-534
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1603786143
- Cited by
- 550
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 19 · 2019: 13 · 2018: 22 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 34 · 2013: 31 · 2012: 31
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM037828, GM R01 37828)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1, insulin resistance, PPARα, type 2 diabetes, hepatic insulin sensitivity, glucose tolerance, Akt signaling, fasting hypoglycemia, nuclear receptors, hepatic gluconeogenesis, RNAi knockdown
- MeSH terms
- Animals, Base Sequence, Diabetes Mellitus, Type 2, DNA, Humans, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Signal Transduction, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Cell Cycle Proteins, RNA Interference, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.